A sponsor needed to enroll at least 200 patients for a pivotal Phase IIIb clinical trial — right when the U.S. issued COVID-19 stay-at-home orders.

Frenova leveraged its clinical research site network and project management expertise to help them exceed their target, activating all sites within three months.

How did we do it?

Screen Shot 2022-02-01 at 1.34.25 PM

Download the Case Study to Find Out